INCENTIVIZING ATTENDANCE TO PROLONGED EXPOSURE FOR PTSD IN OPIOID USE DISORDER PATIENTS: A RANDOMIZED CONTROLLED TRIAL
Loading...
Links to Files
Author/Creator ORCID
Date
2017-04-17
Type of Work
Department
Program
Citation of Original Publication
Schacht, R. L., Brooner, R. K., King, V. L., Kidorf, M. S., & Peirce, J. M. (2017). Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: A randomized controlled trial. Journal of consulting and clinical psychology, 85(7), 689–701. https://doi.org/10.1037/ccp0000208
Rights
This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
©American Psychological Association, 2017. This paper is not the copy of record and may not exactly replicate the authoritative document published in the APA journal. Please do not copy or cite without author's permission. The final article is available, upon publication, at: https://doi.org/10.1037/ccp0000208.
©American Psychological Association, 2017. This paper is not the copy of record and may not exactly replicate the authoritative document published in the APA journal. Please do not copy or cite without author's permission. The final article is available, upon publication, at: https://doi.org/10.1037/ccp0000208.
Subjects
Abstract
OBJECTIVE
To determine whether contingent monetary incentives increase opioid use disorder patients’ attendance to Prolonged Exposure (PE) therapy and whether attendance is associated with improvement in posttraumatic stress disorder (PTSD) and substance use disorder (SUD) outcomes.
METHOD
Patients (N = 58) with PTSD were offered PE or PE with incentives (PE+I; max $480) to attend PE sessions. Participants were assessed at baseline and weeks 6, 12, and 24 post-randomization.
RESULTS
Participants were mostly women (79%) and Caucasian (71%); mean age 37.43 years (SD = 11.33). PE+I participants attended a median of 9 (of 12) sessions compared to 1 session for PE participants (p < 0.001), which included more exposure sessions (PE+I mdn = 6; PE mdn = 0; p < .001). A time × treatment condition interaction indicated that PE+I participants exhibited a greater decrease in PTSD severity over time than PE participants (OR = 3.1; 95% CI = 0.4–5.7; p = 0.024). PE+I participants remained in substance use treatment longer than PE participants (mdn days = 262 vs. 192; p = 0.039). There were no group differences in drug use.